- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 5, 2025 | 45.15M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $22.62M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $14.09M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $41.67M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $36.37M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $23.42M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $26.14M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $49.72M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $53.94M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $4.95M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2024 | $3.54M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 44.25M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 44.03M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $153K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$12.5M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $34.88M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $40.55M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $33.81M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.16 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.31 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.16 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.31 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $6.64M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $13.16M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $2.53M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $4.72M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$6.94M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$13.66M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$6.72M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$6.99M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$14.22M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $2.18M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $3.66M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $3.56M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $6.44M |